Maxitrol and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxitrol (dexamethasone; neomycin sulfate; polymyxin b sulfate) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include diarrhoea among females and tubulointerstitial nephritis among males.

The phase IV clinical study analyzes what interactions people have when they take Maxitrol and Levothyroxine sodium. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Maxitrol?

Maxitrol has active ingredients of dexamethasone; neomycin sulfate; polymyxin b sulfate. eHealthMe is studying from 986 Maxitrol users. Check the latest studies of Maxitrol.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.



On Jul, 06, 2026

24 people who take Maxitrol and Levothyroxine sodium together, and have interactions are studied.

Maxitrol and Levothyroxine sodium drug interactions.

What are the common drug interactions of Maxitrol and Levothyroxine Sodium, by gender? *:

female:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Retinal injury (injury to retina)
  5. Alopecia (absence of hair from areas of the body)
  6. Angle closure glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity)
  7. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  8. Asthenia (weakness)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Blood urea increased

male:

  1. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  2. Chronic kidney disease
  3. Coronary artery atherosclerosis (life-threatening blockages in the arteries of your heart)
  4. Disease progression
  5. Fatigue (feeling of tiredness)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Sudden death
  8. White blood cell count decreased
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Maxitrol and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  4. Dehydration (dryness resulting from the removal of water)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Visual acuity reduced (reduced clearness of vision)
  7. Chronic kidney disease
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 2 people, 8.33%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.33%
  3. Pain: 2 people, 8.33%
  4. Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
  5. Neuralgia (pain in one or more nerves): 2 people, 8.33%
  6. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 8.33%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 8.33%
  8. High Blood Pressure: 2 people, 8.33%
  9. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 8.33%
  10. Diabetes: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Maxitrol and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxitrol and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone; neomycin sulfate; polymyxin b sulfate and levothyroxine sodium (the active ingredients of Maxitrol and Levothyroxine sodium, respectively), and Maxitrol and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: